Molecular formula: | C17H16N8 |
Average mass: | 332.371 |
Monoisotopic mass: | 332.149793 |
ChemSpider ID: | 25057507 |
1216665-49-4
[RN]2,4-Pyrimidinediamine, N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)-
[ACD/Index Name]N2-(1H-1,3-benzodiazol-5-yl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
N~2~-(1H-Benzimidazol-5-yl)-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)-2,4-pyrimidindiamin
[German]
[ACD/IUPAC Name]N~2~-(1H-Benzimidazol-5-yl)-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)-2,4-pyrimidinediamine
[ACD/IUPAC Name]N~2~-(1H-Benzimidazol-5-yl)-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)-2,4-pyrimidinediamine
[French]
[ACD/IUPAC Name]N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
2-N-(1H-1,3-benzodiazol-5-yl)-4-N-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
2-N-(3H-benzimidazol-5-yl)-4-N-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
79397-50-5
[RN]95%
APJ
APY 29;APY-29
APY29 (type I kinase inhibitor)
MFCD27991280
[MDL number]MFCD28023582
[MDL number]N2-(1H-1,3-benzodiazol-5-yl)-N4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
N2-(1H-1,3-benzodiazol-5-yl)-N4-(5-cyclopropyl-2H-pyrazol-3-yl)pyrimidine-2,4-diamine
N2-(1H-Benzo[d]imidazol-6-yl)-N4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
N2-(1H-benzo[d]imidazol-6-yl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
N2-1H-benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-Pyrimidinediamine